{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-003180","form_type":"8-K","ticker":"LTRN","cik":"0001763950","company_name":"Lantern Pharma Inc.","filed_at":"2022-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.119493+00:00","generated_at":"2026-06-27T16:17:05.611523+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lantern Pharma receives Rare Pediatric Disease and Orphan Drug designations for LP-184 in ATRT","bullets":["FDA grants Rare Pediatric Disease Designation and Orphan Drug Designation for LP-184 to treat atypical teratoid rhabdoid tumor (ATRT).","LP-184 is the third Lantern program to receive Orphan Drug Designation; prior designations for pancreatic cancer and malignant glioma.","Rare Pediatric Disease Designation may qualify Lantern for a Priority Review Voucher upon FDA approval of LP-184.","ATRT is an aggressive CNS tumor; nearly 90% of pediatric cases involve SMARCB1 mutations, which LP-184 targets."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-003180","json":"https://secwatch.observer/filing/0001213900-22-003180.json","markdown":"https://secwatch.observer/filing/0001213900-22-003180.md","text":"https://secwatch.observer/filing/0001213900-22-003180.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1763950/000121390022003180/0001213900-22-003180-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1763950/000121390022003180/ea154399-8k_lantern.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T16:17:05.611523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}